TCL Archive FDA approves a new cancer drug, Vidaza, and two sNDAs, without going to ODAC. A date with ODAC may signal a weak case for drug approval, recent approval data indicate. May 28, 2004
TCL Archive Rauscher Tells Flood Subcommittee How He Would Spend An Extra $50 Million-On Centers, Grants April 12, 1974
TCL Archive Senate Committee To Debate Budget Bill Sept. 10; Increase Expected For Breast Cancer Research September 4, 1992
